Rejection After Transplantation

Transplantation of the Liver

Volumn , Issue , 2005, Pages 1167-1182

  Lipshutz, Gerald S ^a   Ascher, Nancy L ^b   Roberts, John P ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42949110393     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0118-2.50077-X     Document Type: Chapter

References (169)

1. SW Chung, PD Greig, MS Cattral, et al. (1997) Evaluation of liver transplantation for high-risk indications. Br J Surg 84 189.
2. DC Snover, RK Sibley, DK Freese, et al. (1984) Orthotopic liver transplantation: A pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology 4 1212.
3. RA Ray, KJ Lewin, J Colonna, et al. (1988) The role of liver biopsy in evaluating acute allograft dysfunction following liver transplantation: A clinical histologic correlation of 34 liver transplants. Hum Pathol 19 835.
4. NL Ascher, PG Stock, GL Bumgardner, et al. (1988) Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet 167 474.
5. AJ Demetris, S Lasky, DH Van Thiel, et al. (1985) Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol 118 151.
6. LR Fisher, KS Henley and MR Lucey (1995) Acute cellular rejection after liver transplantation: Variability, morbidity, and mortality. Liver Transpl Surg 1 10.
7. KP Batts (1999) Acute and chronic hepatic allograft rejection: Pathology and classification. Liver Transpl Surg 5(Suppl 1), S21.
8. AJ Demetris, K Ruppert, I Dvorchik, et al. (2002) Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 74 1290.
9. CA Seiler, EL Renner, A Czerniak, et al. (1999) Early acute cellular rejection: No effect on late hepatic allograft function in man. Transpl Int 12 195.
10. B Dousset, F Conti, B Cherruau, et al. (1998) Is acute rejection deleterious to long-term liver allograft function? J Hepatol 29 660.
11. RH Wiesner, J Ludwig, B van Hoek and RA Krom (1991) Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 14 721.
12. AJ Demetris, N Murase, Q Ye, et al. (1997) Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption. Am J Pathol 150 563.
13. JM Vierling (1999) Immunology of acute and chronic hepatic allograft rejection. Liver Transpl Surg 5(Suppl 1), S1.
14. AS Soin, A Rasmussen, NV Jamieson, et al. (1995) Cyclosporine levels in the early posttransplant period: Predictive of chronic rejection in liver transplantation? Transplant Proc 27 1129.
15. RN Germain (1994) MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76 287.
16. AJ Bathgate, P Hynd, D Sommerville and PC Hayes (1999) The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 5 475.
17. M Maggard, J Goss, S Ramdev, et al. (1998) Incidence of acute rejection in African-American liver transplant recipients. Transplant Proc 30 1492.
18. J Neuberger and D Adams (1998) What is the significance of acute liver allograft rejection? J Hepatol 29 143.
19. RH Wiesner, AJ Demetris, SH Belle, et al. (1998) Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 28 638.
20. J Neuberger (1999) Incidence, timing, and risk factors for acute and chronic rejection. Liver Transpl Surg 5(Suppl 1), S30.
21. O Farges, F Saliba, H Farhamant, et al. (1996) Incidence of rejection and infection after liver transplantation as a function of the primary disease: Possible influence of alcohol and polyclonal immunoglobulins. Hepatology 23 240.
22. L Caregaro, F Alberino, P Amodio, et al. (1996) Malnutrition in alcoholic and virus-related cirrhosis. Am J Clin Nutr 63 602.
23. E Kobayashi, N Kamada, S Goto and M Miyata (1993) Protocol for the technique of orthotopic liver transplantation in the rat. Microsurgery 14 541.
24. SJ Knechtle, JA Wolfe, J Burchette, et al. (1987) Infiltrating cell pheno-types and patterns associated with hepatic allograft rejection or acceptance. Transplantation 43 169.
25. R Calne (1996) WOFIE hypothesis: Some thoughts on an approach toward allograft tolerance. Transplant Proc 28 1152.
26. NL Ascher, RM Ferguson, R Hoffman and RL Simmons (1979) Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 27 254.
27. NL Ascher, S Chen, RA Hoffman and RL Simmons (1983) Maturation of cytotoxic T cells within sponge matrix allografts. J Immunol 131 617.
28. BR Rosengard, CA Ojikutu, PC Guzzetta, et al. (1992) Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine. Transplantation 54 490.
29. Y Tian, HA Rudiger, W Jochum and PA Clavien (2002) Comparison of arterialized and nonarterialized orthotopic liver transplantation in mice: Prowess or relevant model? Transplantation 74 1242.
30. Y Yamaguchi, RC Harland, C Wyble and RR Bollinger (1989) The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. Transplantation 47 171.
31. T Ochiai, K Nakajima, M Nagata, et al. (1987) Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 44 734.
32. TE Starzl, AJ Demetris, M Trucco, et al. (1992) Systemic chimerism in human female recipients of male livers. Lancet 340 876.
33. JW Williams, TG Peters, R Haggitt, et al. (1982) Cyclosporin A in ortho-topic canine hepatic transplants. J Surg Res 32 576.
34. AB Adams, MA Williams, TR Jones, et al. (2003) Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111 1887.
35. AB Adams, TC Pearson and CP Larsen (2003) Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 196 147.
36. SG Hubscher (1991) Histological findings in liver allograft rejection—new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology 18 377.
37. AJ Demetris, SG Qian, H Sun and JJ Fung (1990) Liver allograft rejection: An overview of morphologic findings. Am J Surg Pathol 49(Suppl 1),
38. GW McCaughan, S Davies, J Waugh, et al. (1989) Cell surface phenotype of mononuclear cells infiltrating bile ducts during acute and chronic liver allograft rejection. Transplant Proc 21 2201.
39. JD Perkins, RH Wiesner, PM Banks, et al. (1987) Immunohistologic labeling of infiltrating T lymphocytes in hepatic allografts: A rejection indicator. Transplant Proc 19 2474.
40. JD Perkins, J Rakela, S Sterioff, et al. (1989) Immunohistologic pattern of the portal T-lymphocyte infiltration in hepatic allograft rejection. Mayo Clin Proc 64 565.
41. JD Perkins, J Rakela, S Sterioff, et al. (1988) Results of treatment in hepatic allograft rejection depend on the immunohistologic pattern of the portal T lymphocyte infiltrate. Transplant Proc 20 223.
42. PF Foster, HN Sankary, M Hart, et al. (1989) Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation 47 72.
43. F Kormendi and WJ Amend Jr (1988) The importance of eosinophil cells in kidney allograft rejection. Transplantation 45 537.
44. OM Martinez, EC Burke, TJ Alan and NL Ascher (1991) Allogeneic hepato-cytes stimulate the production of immunoregulatory molecules in mixed lymphocyte hepatocyte cultures. Transplant Proc 23 805.
45. OM Martinez, SM Krams, M Sterneck, et al. (1992) Intragraft cytokine profile during human liver allograft rejection. Transplantation 53 449.
46. EJ Barnes, MM Abdel-Rehim, Y Goulis, et al. (2003) Applications and limitations of blood eosinophilia for the diagnosis of acute cellular rejection in liver transplantation. Am J Transplant 3 432.
47. LM Vaessen, CC Baan, AJ Ouwehand, et al. (1992) Acute rejection in heart transplant patients is associated with the presence of committed donor-specific cytotoxic lymphocytes in the graft but not in the blood. Clin Exp Immunol 88 213.
48. PJ Morris, NP Carter, PR Cullen, et al. (1982) Role of T-cell-subset monitoring in renal-allograft recipients. N Engl J Med 306 1110.
49. HG Herrod, J Williams and PJ Dean (1988) Alterations in immunologic measurements in patients experiencing early hepatic allograft rejection. Transplantation 45 923.
50. AB Cosimi, RB Colvin, RC Burton, et al. (1981) Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med 305 308.
51. S Ibrahim, DV Dawson, PG Killenberg and F Sanfilippo (1993) The pattern and phenotype of T-cell infiltration associated with human liver allograft rejection. Hum Pathol 24 1365.
52. MM Dollinger, SE Howie, JN Plevris, et al. (1998) Intrahepatic proliferation of “naive” and “memory” T cells during liver allograft rejection: Primary immune response within the allograft. FASEB J 12 939.
53. A Weiss and JB Imboden (1987) Cell surface molecules and early events involved in human T lymphocyte activation. Adv Immunol 41 1.
54. O Cuomo and O Perrella (1999) Immune response in liver transplantation: Is there a preferential pattern in acute rejection? Int J Immunopathol Pharmacol 12 63.
55. JJ Fung, A Zeevi, TE Starzl, et al. (1986) Functional characterization of infiltrating T lymphocytes in human hepatic allografts. Hum Immunol 16 182.
56. SL Saidman, AJ Demetris, A Zeevi and RJ Duquesnoy (1990) Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection. Transplantation 49 107.
57. PC Kolbeck, RP Wood and RS Markin (1993) The immunopathology and clinical relevance of lymphocyte cultures in liver transplantation. Mod Pathol 6 307.
58. TG Mayer, AA Fuller, TC Fuller, et al. (1985) Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J Immunol 134 258.
59. A Nocera, S Barocci, U Valente, et al. (1986) In vitro characterization of a donor-specific cytolytic T cell line established from human lymphocytes homing in a rejected kidney allograft. Transplantation 41 135.
60. JF Moreau, M Bonneville, MA Peyrat, et al. (1986) T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/phenotypic analysis. J Clin Invest 78 874.
61. Z Sun, T Wada, K Maemura, et al. (2003) Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transpl 9 489.
62. D Bunjes, C Hardt, M Rollinghoff and H Wagner (1981) Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and inter-leukin 2. Eur J Immunol 11 657.
63. A O'Garra (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8 275.
64. TR Mosmann, H Cherwinski, MW Bond, et al. (1986) Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 2348.
65. TR Mosmann and RL Coffman (1989) TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 145.
66. TB Strom, P Roy-Chaudhury, R Manfro, et al. (1996) The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 8 688.
67. TR Mosmann and KW Moore (1991) The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 12 A49.
68. MD Sadick, FP Heinzel, BJ Holaday, et al. (1990) Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 171 115.
69. SM Wren, SC Wang, NL Thai, et al. (1993) Evidence for early Th 2 T cell predominance in xenoreactivity. Transplantation 56 905.
70. J Li, Y Yang, H Inoue, et al. (1996) The expression of costimulatory molecules CD80 and CD86 in human carcinoma cell lines: Its regulation by interferon gamma and interleukin-10. Cancer Immunol Immunother 43 213.
71. H Groux, M Bigler, JE de Vries and MG Roncarolo (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184 19.
72. AB Zhang, SS Zheng, CK Jia and Y Wang (2003) Effect of 1,25-dihydroxy-vitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol 9 1067.
73. KJ Lafferty, SJ Prowse, CJ Simeonovic and HS Warren (1983) Immunobiology of tissue transplantation: A return to the passenger leukocyte concept. Annu Rev Immunol 1 143.
74. DA Cantrell and KA Smith (1983) Transient expression of interleukin 2 receptors. Consequences for T cell growth. J Exp Med 158 1895.
75. SM Krams and OM Martinez (1998) Apoptosis as a mechanism of tissue injury in liver allograft rejection. Semin Liver Dis 18 153.
76. T Patel and GJ Gores (1998) Apoptosis in liver transplantation: A mechanism contributing to immune modulation, preservation injury, neoplasia, and viral disease. Liver Transpl Surg 4 42.
77. U Landegren, U Ramstedt, I Axberg, et al. (1982) Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies. J Exp Med 155 1579.
78. CP Larsen, PJ Morris and JM Austyn (1990) Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J Exp Med 171 307.
79. GL Bumgardner, S Chen, R Hoffman and NL Ascher (1989) Responder T-cell subsets and antigenic stimulus in mixed lymphocyte-hepatocyte culture. Curr Surg 46 20.
80. SK So, LM Wilkes, JL Platt, et al. (1987) Purified hepatocytes can stimulate allospecific cytolytic T lymphocytes in a mixed lymphocyte-hepatocyte culture. Transplant Proc 19 251.
81. GL Bumgardner, S Chen, PS Almond, et al. (1992) Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts. Transplantation 53 857.
82. GL Bumgardner, S Chen, PS Almond, et al. (1992) Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated “memory” cells to class I+class II-hepatocytes. Transplantation 53 863.
83. K Hockerstedt, I Lautenschlager, J Ahonen, et al. (1988) Diagnosis of acute rejection in liver transplantation. J Hepatol 6 217.
84. L Takacs, B Szende, E Monostori, et al. (1983) Expression of HLA-DR antigens on bile duct cells of rejected liver transplant. Lancet 2 1500.
85. GL Bumgardner, N Ascher and S Chen (1989) Immunosuppressive factors in hepatocyte and liver cytosol. Surg Forum 30 391.
86. RW Osorio, NL Ascher, R Jaenisch, et al. (1993) Isolation of functional MHC class I-deficient islet cells. Transplant Proc 25 968.
87. AS Daar, SV Fuggle, JW Fabre, et al. (1984) The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38 287.
88. G Steinhoff, K Wonigeit and R Pichlmayr (1988) Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 45 394.
89. EC Burke, OM Martinez, CE Freise, et al. (1991) MHC expression on human hepatocytes before and after isolation. Transplant Proc 23 1428.
90. SM Clemmings, TJ Alan, GL Bumgardner and NL Ascher (1991) Lack of class II antigen expression on hepatocytes profoundly affects CTL development in vitro and in vivo. Transplant Proc 23 817.
91. SK So, JL Platt, NL Ascher and DC Snover (1987) Increased expression of class I major histocompatibility complex antigens on hepatocytes in rejecting human liver allografts. Transplantation 43 79.
92. P Hayry (1984) Intragraft events in allograft destruction. Transplantation 38 1.
93. NL Tilney, J Notis-McConarty and TB Strom (1978) Specificity of cellular migration into cardiac allografts in rats. Transplantation 26 181.
94. HS Warren, CJ Simeonovic, JE Dixon, et al. (1986) Sensitized Lyt-2+ T cells trigger rejection of grafts expressing class I major histocompatibility complex alloantigens. Transplant Proc 18 310.
95. D Faustman, V Hauptfeld, P Lacy and J Davie (1981) Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc Natl Acad Sci U S A 78 5156.
96. PG Stock, M Meloche, NL Ascher, et al. (1989) Generation of allospecific cytolytic T-lymphocytes stimulated by pure pancreatic beta-cells in absence of Ia+ dendritic cells. Diabetes 38(Suppl 1), 161.
97. JM Cecka, YW Cho and PI Terasaki (1992) Analyses of the UNOS Scientific Renal Transplant Registry at three years—early events affecting transplant success. Transplantation 53 59.
98. SJ Knechtle, M Kalayolu, AM D'Alessandro, et al. (1993) Histocompatibility and liver transplantation. Surgery 114 667.
99. BH Markus, JJ Fung, RD Gordon, et al. (1987) HLA histocompatibility and liver transplant survival. Transplant Proc 19(Suppl 3), 63.
100. D Seehofer, N Rayes, SG Tullius, et al. (2002) CMV hepatitis after liver transplantation: Incidence, clinical course, and long-term follow-up. Liver Transpl 8 1138.
101. A Yagihashi, M Kobayashi, K Noguchi, et al. (1992) HLA matching effect in liver transplantation. Transplant Proc 24 2432.
102. HS Davies, SG Pollard and RY Calne (1989) Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 47 524.
103. VK Rhynes, JC McDonald, FB Gelder, et al. (1993) Soluble HLA class I in the serum of transplant recipients. Ann Surg 217 485.
104. JS Singer, A Mhoyan, MC Fishbein, et al. (2001) Allochimeric class I MHC molecules prevent chronic rejection and attenuate allo-antibody responses. Transplantation 72 1408.
105. S Iwatsuki, Y Iwaki, T Kano, et al. (1981) Successful liver transplantation from crossmatch-positive donors. Transplant Proc 13 286.
106. RD Gordon, JJ Fung, B Markus, et al. (1986) The antibody crossmatch in liver transplantation. Surgery 100 705.
107. S Takaya, O Bronsther, Y Iwaki, et al. (1992) The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 53 400.
108. KP Batts, SB Moore, JD Perkins, et al. (1988) Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts. Transplantation 45 376.
109. R Charco, V Vargas, J Balsells, et al. (1996) Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation. J Hepatol 24 452.
110. MW Flye, BF Duffy, DL Phelan, et al. (1990) Protective effects of liver transplantation on a simultaneously transplanted kidney in a highly sensitized patient. Transplantation 50 1051.
111. G Bird, P Friend, P Donaldson, et al. (1989) Hyperacute rejection in liver transplantation: A case report. Transplant Proc 21 3742.
112. J Fung, L Makowka, A Tzakis, et al. (1988) Combined liver-kidney transplantation: Analysis of patients with preformed lymphocy-totoxic antibodies. Transplant Proc 20(Suppl 1), 88.
113. R Margreiter, R Kornberger, J Koller, et al. (1987) Preliminary results with combined hepatorenal transplantation. Transplant Proc 19 3552.
114. RD Gordon, S Iwatsuki, CO Esquivel, et al. (1987) Experience with primary liver transplantation across ABO blood groups. Transplant Proc 19 4575.
115. M Tanabe, M Shimazu, G Wakabayashi, et al. (2002) Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73 1959.
116. M Kasahara, T Kiuchi, K Uryuhara, et al. (2002) Role of HLA compatibility in pediatric living-related liver transplantation. Transplantation 74 1175.
117. V Shah and PS Kamath (2003) Nitric oxide in liver transplantation: Pathobiology and clinical implications. Liver Transpl 9 1.
118. Y Yamaguchi, K Okabe, F Matsumura, et al. (1999) Peroxynitrite formation during rat hepatic allograft rejection. Hepatology 29 777.
119. JM Langrehr, N Murase, PM Markus, et al. (1992) Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 90 679.
120. PC Kuo, EJ Alfrey, KY Abe, et al. (1996) Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation. Transplantation 61 305.
121. M Goto, Y Yamaguchi, O Ichiguchi, et al. (1997) Phenotype and localization of macrophages expressing inducible nitric oxide synthase in rat hepatic allograft rejection. Transplantation 64 303.
122. MR Schaffer, N Fuchs, B Proksch, et al. (1998) Tacrolimus impairs wound healing: A possible role of decreased nitric oxide synthesis. Transplantation 65 813.
123. I Ioannidis, A Hellinger, C Dehmlow, et al. (1995) Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 59 1293.
124. M Romero, C Garcia-Monzon, G Clemente, et al. (2001) Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: Evidence of modulation by corticosteroids. Liver Transpl 7 16.
125. J Devlin, RM Palmer, CE Gonde, et al. (1994) Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 58 592.
126. GE Ranges, IS Figari, T Espevik and MA Palladino Jr (1987) Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 166 991.
127. MH Thornhill, SM Wellicome, DL Mahiouz, et al. (1991) Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1–dependent and -independent binding mechanisms. J Immunol 146 592.
128. PF Halloran, SM Cockfield and J Madrenas (1989) The mediators of inflammation (interleukin 1, interferon-tau, and tumor necrosis factor) and their relevance to rejection. Transplant Proc 21 26.
129. DK Imagawa, JM Millis, KM Olthoff, et al. (1990) The role of tumor necrosis factor in allograft rejection. 1. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation 50 219.
130. DK Imagawa, JM Millis, KM Olthoff, et al. (1990) The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation 50 189.
131. T Kishimoto and T Hirano (1988) Molecular regulation of B lymphocyte response. Annu Rev Immunol 6 485.
132. GG Wong and SC Clark (1988) Multiple actions of interleukin 6 within a cytokine network. Immunol Today 9 137.
133. H Ohzato, M Monden, K Yoshizaki, et al. (1993) Serum interleukin-6 levels as an indicator of acute rejection after liver transplantation in cynomolgus monkeys. Surg Today 23 521.
134. G Hamilton, M Prettenhofer, A Zommer, et al. (1991) Intraoperative course and prognostic significance of endotoxin, tumor necrosis factor-alpha and interleukin-6 in liver transplant recipients. Immunobiology 182 425.
135. RB Colvin, FI Preffer, T Fuller, et al. (1989) A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients. Transplant Proc 21 1863.
136. D Cantarovich, B Le Mauff, M Hourmant, et al. (1988) Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantation. Am J Kidney Dis 11 101.
137. F Conti, J Frappier, S Dharancy, et al. (2003) Interleukin-15 production during liver allograft rejection in humans. Transplantation 76 210.
138. RH Wiesner, J Rakela, MB Ishitani, et al. (2003) Recent advances in liver transplantation. Mayo Clin Proc 78 197.
139. RJ Firpi, MF Abdelmalek, C Soldevila-Pico, et al. (2002) Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl 8 1000.
140. M Prieto, M Berenguer, JM Rayon, et al. (1999) High incidence of allograft cirrhosis in hepatitis C virus genotype lb infection following transplantation: Relationship with rejection episodes. Hepatology 29 250.
141. LD Ferrell, TL Wright, J Roberts, et al. (1992) Hepatitis C viral infection in liver transplant recipients. Hepatology 16 865.
142. AR Mueller, KP Platz, T Berg, et al. (1997) Association between hepatitis and rejection: Upregulation of cytokines and extracellular matrix parameters. Transplant Proc 29 2843.
143. AP Dhillon and GM Dusheiko (1995) Pathology of hepatitis C virus infection. Histopathology 26 297.
144. LM Petrovic, FG Villamil, JM Vierling, et al. (1997) Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg 3 398.
145. U Khettry, C Robiou, R Jenkins, et al. (1998) Recurrent hepatitis C in liver allografts: Early histologic indicators. Intern J Surg Pathol 6 197.
146. A Demetris, K Batts, A Dhillon, et al. (1997) Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 25 658.
147. R Saxena, JM Crawford, VJ Navarro, et al. (2002) Utilization of acidophil bodies in the diagnosis of recurrent hepatitis C infection after orthotopic liver transplantation. Mod Pathol 15 897.
148. C Duvoux, JM Pawlotsky, D Cherqui, et al. (1995) Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfection. Transplantation 60 457.
149. KL Aardema, RE Nakhleh, LK Terry, et al. (1999) Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants. Mod Pathol 12 1043.
150. EJ Gane, NV Naoumov, KP Qian, et al. (1996) A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110 167.
151. MJ Gottschlich, KL Aardema, EM Burd, et al. (2001) The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C. Liver Transpl 7 436.
152. W Sreekumar, G Gores, C Rosen, et al. (2000) Differential gene expression patterns in HCV infected allografts during acute cellular rejection [abstract]. Hepatology 32 260A.
153. A Tannapfel, F Geissler, H Witzigmann, et al. (2001) Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen. Transplant Proc 33 3283.
154. A Zekry, GA Bishop, DG Bowen, et al. (2002) Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury. Liver Transpl 8 292.
155. P Ciccorossi, F Filipponi, F Oliveri, et al. (2003) Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares. J Viral Hepat 10 168.
156. EJ Gane, BC Portmann, NV Naoumov, et al. (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334 815.
157. PA Sheiner, ME Schwartz, E Mor, et al. (1995) Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 21 30.
158. GW McCaughan and A Zekry (2002) Pathogenesis of hepatitis C virus recurrence in the liver allograft. Liver Transpl 8(Suppl 1), S7.
159. SC Abraham and EE Furth (1995) Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology. Transplantation 59 740.
160. JW Williams, TG Peters, SR Vera, et al. (1985) Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation 39 589.
161. KS Henley, MR Lucey, HD Appelman, et al. (1992) Biochemical and histopathological correlation in liver transplant: The first 180 days. Hepatology 16 688.
162. I Lautenschlager, K Hockerstedt and P Hayry (1991) Fine-needle aspiration biopsy in the monitoring of liver allografts. Transpl Int 4 54.
163. I Lautenschlager, K Hockerstedt, E Taskinen, et al. (1988) Fine-needle aspiration biopsy in the monitoring of liver allografts. T. Correlation between aspiration biopsy and core biopsy in experimental pig liver allografts. Transplantation 46 41.
164. K Kubota, FP Reinholt, G Tyden and CG Groth (1989) Recent experience with pancreatic juice cytology in monitoring pancreatic graft rejection. Transplant Proc 21 3643.
165. T Topalidis, WO Bechstein, C Bohmann, et al. (1993) New preparation method for bile cytology in liver transplantation: Diagnosis of rejection. Transplant Proc 25 1979.
166. KJ Oldhafer, G Gubernatis, B Ringe and R Pichlmayr (1990) Experience with bile cytology after liver transplantation. Transplant Proc 22 1524.
167. K Kubota, BG Ericzon and FP Reinholt (1990) Diagnosis of liver transplant rejection by bile cytology. Transplant Proc 22 1521.
168. I Roberti, KV Lieberman, C Manzarbeitia, et al. (1992) Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection. Transplantation 54 471.
169. DG Ormonde, WB de Boer, A Kierath, et al. (1999) Banff schema for grading liver allograft rejection: Utility in clinical practice. Liver Transpl Surg 5 261.